KİŞİSEL BİLGİLER
Adı Soyadı Prof. Dr. Barış AFŞAR
Birimi Tıp Fakültesi
Bölüm Dahili Tıp Bilimleri Bölümü
Ana Bilim Dalı İç Hastalıkları Anabilim Dalı
E-Posta barisafsar@sdu.edu.tr
YÖK Akademik Adrese Gitmek İçin Tıklayınız.
Bu sayfadaki kişisel verilerin görünürlüğü KVKK 8. madde hükmü uyarınca ilgili kişinin açık rızası kapsamındadır. Kişisel verilerinizin görünürlüğünü veya hali hazırdaki verilerinizi Personel Bilgi Sistemi'nden (PBS) düzenleyebilirsiniz.
ÖĞRENİM BİLGİLERİ
Lisans HACETTEPE ÜNİVERSİTESİ - 30.06.1999
Yüksek Lisans
Doktora
AKADEMİK YAYIN ANALİZLERİ
İLGİ ALANLARI
YAYINLAR
  • Alanında, yurtdışında yayımlanan kitap
  • 1 ResistantHypertensionin ChronicKidney Disease (Treatment of Hypertension in Light of the New Guidelines: Salt Intake)
  • 2 Resistant Hypertension in Chronic Kidney Disease (Treatment of Hypertension in Light of the New Guidelines: Drug Adherence)
  • Alanında, yurtdışında yayımlanan kitapta bölüm ve ünite yazarlığı
  • 1 Dyslipidemias in Kidney Disease
  • 2 Cardio-Renal Clinical Challenges
  • Hakemli dergilerde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden yayınlar dışındaki makale
  • 1 Association Between Elevated Serum Uric Acid and Vitamin D Insufficiency Among the Middle-Aged and Elderly Population
  • 2 Hemodiyaliz Hastalarında Beslenme ve Yaşam Kalitesi
  • 3 The Relationship Between Parathyroid Hormone, Insulin Resistance and Blood Pressure in Newly Diagnosed Hypertensive Patients with Various Levels of Kidney Function
  • 4 The Relationship Between Daytime, Nighttime and 24-Hour Heart Rate with Urinary Albumin and Protein Excretion in Patients with Newly Diagnosed Type 2 Diabetes
  • 5 Baseline Demographic, Clinical and Laboratory Parameters Related with 24 Hour Urinary Sodium Excretion in Newly Diagnosed Patients with Type 2 Diabetes
  • 6 Böbrek Nakli Sonrası Tekrarlayan Glomerülonefritler
  • 7 The Relationship Between Cognitive Function and Urinary Albumin Excretion in Type 2 Diabetic Patients
  • 8 Yo??un Bak?m Ünitesinde Akut Böbrek Yetmezli??inin Patogenezi, Prognozu ve Tedavisi
  • 9 Nephrogenic Systemic Fibrosis: An Update and Literature Review
  • 10 Hepatit C Enfeksiyonu ve Diyaliz: Genel bir Bakış
  • 11 A Survey of Peritonitis of our Continuous Ambulatory Peritoneal Dialysis Patients
  • 12 Son Dönem Böbrek yetmezliği hastalarının Nütrisyonel Durumlarının Degerlendirilmesinde Kukkanılan Yöntemler
  • Diğer bilimsel dergilerde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden yayınlar dışındaki makale
  • 1 Elevated Uric Acid Levels as Another Cause of Erectile Dysfunction: Hypothesis and Rationale?
  • SCI, SSCI ve AHCI dışındaki indeks ve özler tarafından taranan dergilerde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden yayınlar dışındaki makale
  • 1 Hepatitis C infection in hemodialysis patients: Protective against oxidative stress?
  • 2 Pathophysiology of copeptin in kidney disease and hypertension
  • SCI, SSCI ve AHCI tarafından taranan dergilerde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden yayınlar dışındaki makale
  • 1 Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
  • 2 Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography
  • 3 Effect of Uric Acid-Lowering Agents on Cardiovascular Outcome in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies
  • 4 Noninvasive optical coherence tomography imaging correlates with anatomic and physiologic end-organ changes in healthy normotensives with systemic blood pressure variability
  • 5 The Effect of Urine pH and Urinary Uric Acid Levels on the Development of Contrast Nephropathy
  • 6 Can Incidental Vascular Calcifications at Mammography be Used as a Screening Biomarker for Heart and Kidney Disease?
  • 7 Multilayered Interplay Between Fructose and Salt in Development of Hypertension
  • 8 The effect of chronic kidney disease on lipid metabolism
  • 9 Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease
  • 10 The role of endothelial glycocalyx in health and disease
  • 11 Antidiuretic Hormone and Serum Osmolarity Physiology and Related Outcomes: What Is Old, What Is New, and What Is Unknown?
  • 12 A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease
  • 13 Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality
  • 14 The role of uric acid in mineral bone disorders in chronic kidney disease
  • 15 Air pollution and kidney disease: review of current evidence
  • 16 Cardiovascular Effects of Continuous Positive Airway Pressure Treatment in Patients With Obstructive Sleep Apnea: A Meta-Analysis
  • 17 Iron in kidney and heart failure: from theory to practice.
  • 18 The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review
  • 19 Capillary rarefaction from the kidney point of view
  • 20 Disorders of Lipid Metabolism in Chronic Kidney Disease
  • 21 Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome
  • 22 The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus
  • 23 The Future of IL-1 Targeting in Kidney Disease
  • 24 Hyperthermic intraperitonal chemotherapy is an independent risk factor fordevelopment of acute kidney injury.
  • 25 Acute effects of salt on blood pressure are mediated by serum osmolality
  • 26 Salt Intake and Immunity
  • 27 Pazopanib-Induced Hepatotoxicity in an Experimental Rat Model
  • 28 Iron in kidney and heart failure: from theory to practice
  • 29 Heart failure with preserved ejection fraction:a nephrologist-directed primer
  • 30 Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension
  • 31 Addition of silymarin to renin–angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial
  • 32 Serum Uric Acid and Risk for Acute Kidney Injury Following Contrast
  • 33 The role of sodium intake in nephrolithiasis: epidemiology, pathogenesis, and future directions.
  • 34 Heart failure with preserved ejection fraction: a nephrologist-directed primer.
  • 35 Uric Acid is a Useful Tool to Predict Contrast-Induced Nephropathy
  • 36 Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients
  • 37 Hypertension as an autoimmune and inflammatory disease
  • 38 Novel Masters of Erythropoiesis: Hypoxia Inducible Factors and Recent Advances in Anemia of Renal Disease
  • 39 Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival
  • 40 Severity of coronary artery disease is an independent risk factor for decline in kidney function
  • 41 Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis
  • 42 Brain-kidney cross-talk: Definition and emerging evidence
  • 43 Gut hormones and gut microbiota: implications for kidney function and hypertension
  • 44 The relationship between weight, height and body mass index with hemodynamic parameters is not same in patients with and without chronic kidney disease
  • 45 Morning Blood Pressure Surge as a Predictor of Development of Chronic Kidney Disease
  • 46 Serum sclerostin levels, arteriovenous fistula calcification and 2-years all-cause mortality in prevalent hemodialysis patients
  • 47 The Role of Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio to Predict New Cardiovascular Events in Essential Hypertensive Patients
  • 48 Focus on renal congestion in heart failure
  • 49 Disruption of circadian blood pressure, heart rate and the impact on glycemic control in type 1 diabetes
  • 50 Urinary Sodium Excretion and Ambulatory Blood Pressure Findings in Patients With Hypertension
  • 51 Persistence of Cardiovascular Risk Factors in Women With Previous Preeclampsia
  • 52 Association between serum bicarbonate and pH with depression, cognition and sleep quality in hemodialysis patients
  • 53 Renalase: Another puzzle piece between hypertension and simple renal cysts?
  • 54 Phosphodiesterase type 5 inhibitors and kidney disease
  • 55 Central hemodynamics, vascular stiffness, and nocturia in patients with type 2 diabetes
  • 56 Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia
  • 57 Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients
  • 58 Sclerostin as a new key player in arteriovenous fistula calcification
  • 59 Morning blood pressure surge is associated with serum gamma-glutamyltransferase activity in essential hypertensive patients
  • 60 The Relationship Between Neutrophil Lymphocyte Ratio With Urinary Protein Albumin Excretion in Newly Diagnosed Patients With Type 2 Diabetes
  • 61 The relationship between magnesium and ambulatory blood pressure, augmentation index, pulse wave velocity, total peripheral resistance, and cardiac output in essential hypertensive patients
  • 62 The relationship between intact parathyroid hormone levels and daily physical activity in hemodialysis patients
  • 63 Relationship between kidney length and cortical thickness and circadian blood pressure measurements in hypertensive patients.
  • 64 An Update on Coronary Artery Disease and Chronic Kidney Disease
  • 65 The relationship between central hemodynamics, morning blood pressure surge, glycemic control and sodium intake in patients with type 2 diabetes and essential hypertension
  • 66 Serum uric acid and arterial stiffness in hypertensive chronic kidney disease patients
  • 67 Relationship Between Elevated Morning Blood Pressure Surge, Uric Acid, and Cardiovascular Outcomes in Hypertensive Patients
  • 68 The Relationship of Serum Cortisol Levels with Depression, Cognitive Function and Sleep Disorders in Chronic Kidney Disease and Hemodialysis Patients
  • 69 Endocan: A New Molecule Playing a Role in the Development of Hypertension and Chronic Kidney Disease?
  • 70 The relationship between aortic knob width and various demographic, clinical, and laboratory parameters in stable hemodialysis patients.
  • 71 The relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysis
  • 72 Relationship between total testosterone, cognitive function, depressive behavior, and sleep quality in chronic kidney disease patients not on dialysis
  • 73 The Relationship Between Sleep Quality and Daytime Sleepiness and Various Anthropometric Parameters in Stable Patients Undergoing Hemodialysis
  • 74 Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor?
  • 75 Are there any seasonal changes of cognitive impairment, depression, sleep disorders and quality of life in hemodialysis patients?
  • 76 The Relationship between Red Cell Distribution Width with Erythropoietin Resistance in Iron Replete Hemodialysis Patients
  • 77 Comparison of demographic, clinical, laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension
  • 78 The role of uric acid in the pathogenesis of human cardiovascular disease
  • 79 The relationship between self-reported nocturnal sleep duration, daytime sleepiness and 24-h urinary albumin and protein excretion in patients with newly diagnosed type 2 diabetes
  • 80 The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention
  • 81 The Relationship Between Cognitive Function, Depressive Behaviour and Sleep Quality with 24-h Urinary Sodium Excretion in Patients with Essential Hypertension
  • 82 Bone Pain Assessment and Relationship with Parathyroid Hormone and Health-Related Quality of Life in Hemodialysis
  • 83 Urinary albumin, protein excretion and circadian blood pressure in patients with fibromyalgia
  • 84 The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores
  • 85 The impact of inflammatory factors associated with primary arteriovenous failure
  • 86 The Comparison of 24-Hour Urinary Sodium, Albumin, and Protein Excretion in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus Using Insulin Detemir or Insulin Glargine
  • 87 The relation between Internet and social media use and the demographic and clinical parameters, quality of life, depression, cognitive function and sleep quality in hemodialysis patients: social media and hemodialysis.
  • 88 Microalbuminuria, Kidney Function, and Daily Physical Activity
  • 89 The Relationship Between Erythropoietin Resistance and Antibody Response to Hepatitis B Vaccine in Hemodialysis Patients
  • 90 HbA1c Is Related with Uremic Pruritus in Diabetic and Nondiabetic Hemodialysis Patients
  • 91 The primary arteriovenous fistula failure—a comparison between diabetic and non-diabetic patients: glycemic control matters
  • 92 The independent relationship between creatinine clearance, microalbuminuria and circadian blood pressure levels in newly diagnosed essential hypertensive and type 2 diabetic patients
  • 93 The Relationship Between Serum Total Testosterone and 24-hour Urinary Sodium Excretion in Never Treated Stage I Essential Hypertensive Patients
  • 94 The relationship between breakfast, lunch and dinner eating pattern and hemodialysis sessions, quality of life, depression and appetite in hemodialysis patients
  • 95 Vascular access type, health-related quality of life, and depression in hemodialysis patients: a preliminary report
  • 96 Sociodemographic, Clinical, and Laboratory Parameters Related with Presence of Regular Toothbrushing in Hemodialysis Patients
  • 97 Simple renal cysts and circadian blood pressure: are they related to each other in patients with hypertension?
  • 98 Targeting Parathyroid Hormone Level in Diabetic Patients With Stage 3 to 5 Chronic Kidney Disease: Does Metabolic Syndrome Matter?
  • 99 Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
  • 100 Helicobacter pylori Infection: Protective Against Increased Interdialytic Weight Gain in Asymptomatic Hemodialysis Patients?
  • 101 Which Anthropometric Parameter Is Best Related With Urinary Albumin Excretion and Creatinine Clearance in Type 2 Diabetes: Body Mass Index, Waist Circumference, Waist-to-Hip Ratio, or Conicity Index?
  • 102 Uric acid as a cardiometabolic risk factor: to be or not to be.
  • 103 Relationship between Uric Acid and Subtle Cognitive Dysfunction in Chronic Kidney Disease
  • 104 Insulin resistance is associated with increased renal resistive index independent of other factors in newly diagnosed type 2 diabetes mellitus and hypertensive patients
  • 105 Arterial stiffness in dialysis patients: where are we now?
  • 106 Peritoneal cells at admission: do they have prognostic significance in peritonitis?
  • 107 Nondipping Phenomenon and Quality of Life: Are They Related in Essential Hypertensive Patients?
  • 108 Acinetobacter co-infection and coagulase-negative Staphylococcus : case report and literature review
  • 109 Irritable bowel syndrome in haemodialysis: Prevalence, link with quality of life and depression
  • 110 Urinary albumin excretion among nondipper hypertensive patients is closely related with the pattern of nondipping
  • 111 Sudden Death in Hemodialysis: An Update
  • 112 Renal resistive index and nocturnal non-dipping: Is there an association in essential hypertension?
  • 113 Quality of life is not related with liver disease severity but with anemia, malnutrition, and depression in HCV-infected hemodialysis patients
  • 114 Quality of life in hemodialysis patients: hepatitis C virus infection makes sense
  • 115 Does Metabolic Syndrome Have an Impact on the Quality of Life and Mood of Hemodialysis Patients?
  • 116 Antibody response following hepatitis B vaccination in dialysis patients: Does depression and life quality matter?
  • 117 Peritoneal albumin leakage: 2â??year prospective cardiovascular event occurrence and patient survival analysis
  • 118 Factors Related to Silent Myocardial Damage in Hemodialysis Patients
  • 119 Uric acid and nocturnal nondipping in hypertensive patients with normal renal function.
  • 120 Malnutrition inflammation score is associated with coronary artery disease in hepatitis C virus-infected hemodialysis patients
  • 121 Lipid Profile During Azathioprine or Mycophenolate Mofetil Combinations With Cyclosporine and Steroids
  • 122 Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?
  • 123 Adherence, depression and quality of life in patients on a renal transplantation waiting list
  • 124 Peritoneal Small Solute Transport Rate Is Related to the Malnutrition Inflammation Score in Peritoneal Dialysis Patients
  • 125 Additional Effect of Hyperparathyroidism on Inflammatory Status and rHuEPO Requirements in Hemodialysis Patients
  • 126 Hepatitis C Infection in Hemodialysis Patients: Protective Against Oxidative Stress?
  • 127 Persistent Hypercalcemia Is a Significant Risk Factor for Graft Dysfunction in Renal Transplantation Recipients
  • 128 Subjective Global Assessment Is a Useful Method to Detect Malnutrition in Renal Transplant Patients
  • 129 Reliability of Mini Nutritional Assessment in Hemodialysis Compared With Subjective Global Assessment
  • 130 Malnutrition-inflammation score is a useful tool in peritoneal dialysis patients.
  • Alanında makale, kitap bölümü ve karar tahlili çevirisi
  • 1 Hemodiyaliz Damar Giriş Yolunun Tarihçesi:Scribner Deneyimi
  • 2 Girişimsel Nefrolojinin Birleşik Devletlerdeki Tarihçesi
  • 3 Global Perspektif Açısından Girişimsel Nefrolojinin Tarihi
  • 4 Hemodiyaliz Damar Yolu Epidemiyolojisi: Global Bir Bakış
  • SCI, SSCI ve AHCI tarafından taranan dergilerde yayımlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden yayın
  • 1 Hypoxia inducible factor-1 protects against COVID-19: A hypothesis
  • 2 Intravenous Iron and Maintenance Hemodialysis
  • 3 Effect of Social, regional, and education status and season on blood pressure
  • 4 Is relative overhydration measurement by bioimpedance spectroscopy useful in reducing morbidity and mortality in chronic kidney disease?
  • 5 Ambulatory Blood Pressure and Mortality
  • 6 Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
  • 7 Ascorbic acid: a promising agent in chronic kidney disease?
  • 8 Increased renal resistive index in type 2 diabetes: Clinical relevance, mechanisms and future directions
  • 9 Should we take renal denervation with a grain of salt?
  • 10 Renal artery intervention utilizing carbon dioxide angiography
  • 11 Atherosclerotic renal artery stenosis in the post-CORAL era part 1: the renal penumbra concept and next-generation functional diagnostic imaging
  • 12 Are All ß-Blockers the Same? Nebivolol Vasodilator Properties and Evidence for Relevance in Treatment of Hypertension
  • 13 Reply to: Hemodynamic and Arterial Stiffness Parameters in Ambulatory Blood Pressure Phenotypes and the Clinical Scenario of Polypharmacy and Comorbidities
  • 14 Re: Comment on “Body shape index and mortality in hemodialysis patients”
  • 15 Renal Artery Stenting in Patients With Uncontrolled Hypertension: Should We? And to Whom?
  • 16 Do We Have to Shift Three Doses of Hepatitis B Vaccine Instead of Four Doses in Chronic Renal Failure: Think Before Action
  • 17 Body shape index and mortality in hemodialysis patients
  • 18 Simple renal cyst and hypertension
  • 19 Waist Circumference and Mortality: Is Albuminuria the Missing Link?
  • 20 Comparison of renal resistive index among patients with Type 2 diabetes with different levels of creatinine clearance and urinary albumin excretion
  • 21 Testosterone and Blood Pressure: Is the Decreased Sodium Excretion the Missing Link?
  • 22 Circadian Blood Pressure and Target Organ Damage: More Is Needed
  • 23 Waist Circumference and Hypertension: Also Applicable in Diabetic Patients?
  • 24 The Pattern of Nondipping and Urinary Albumin Excretion
  • 25 Waist circumference and mortality in dialysis patients: steps to go
  • 26 Data are cumulating about elevated troponin I levels in asymptomatic dialysis patients
  • 27 Mean platelet volume is not a determinant of primary arteriovenous fistula failure in hemodialysis patients
  • 28 Malnutrition-Inflammation Complex Syndrome in Kidney Transplant Recipients
  • 29 Troponin I and Cardiovascular Events in Transplant Patients
  • 30 Atherosclerotic renal artery disease and heart failure: questions in mind
  • 31 Regular Lactulose Use Is Associated with Lower Peritonitis Rates: an Observational Study
  • 32 Sudden cardiac death and mineral metabolism in chronic kidney disease
  • 33 Depression and nonadherence are closely related in dialysis patients
  • 34 Do patients with uric acid stones exhibit abnormal circadian blood pressure--a hypothesis
  • 35 Malnutrition-inflammation score in peritoneal dialysis: growing reliability.
  • 36 Gastric carcinoid tumour: occurrence in a systemic lupus erythematosus patient with end-stage renal disease
  • 37 Helicobacter pylori infection may increase renal resistive index
  • 38 Does Helicobacter pylori play a role in nocturnal non-dipping?
  • 39 Mixed connective tissue disease: a case with scleroderma renal crisis following abortion
  • 40 Acute tubulointerstitial nephritis and acute leukemia: report of 2 cases.
  • 41 The Prognostic Significance of Renal Resistive Index in Essential Hypertension
VERDİĞİ DERSLER
 
Bu İçeriği Paylaş!